600276 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co. (600276) news
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600276, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Jiangsu Hengrui Pharmaceuticals Co. news
We have not published a story on Jiangsu Hengrui Pharmaceuticals Co. yet. When there is news, it will appear here.
Questions about Jiangsu Hengrui Pharmaceuticals Co.
What is the ticker symbol of Jiangsu Hengrui Pharmaceuticals Co.?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. trades under the ticker 600276 on SSE.
Where is Jiangsu Hengrui Pharmaceuticals Co. listed?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is listed on SSE. Our directory also records these other listings: BMV:1276/N; GETTEX:0BO; HKEX:1276; LS:A41984; LSX:A41984; OTC:JHPCY.
What is the SEC CIK of Jiangsu Hengrui Pharmaceuticals Co.?
The SEC Central Index Key (CIK) for Jiangsu Hengrui Pharmaceuticals Co., Ltd. is 2071868. Its filings are on SEC EDGAR.
Which country or territory is Jiangsu Hengrui Pharmaceuticals Co. listed under?
Our directory records Jiangsu Hengrui Pharmaceuticals Co., Ltd. under China.
What does Jiangsu Hengrui Pharmaceuticals Co. do?
Our directory classifies Jiangsu Hengrui Pharmaceuticals Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Jiangsu Hengrui Pharmaceuticals Co.?
The ISIN recorded for Jiangsu Hengrui Pharmaceuticals Co., Ltd. is CNE0000014W7.
Does aibio.space cover Jiangsu Hengrui Pharmaceuticals Co.?
aibio.space lists Jiangsu Hengrui Pharmaceuticals Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Jiangsu Hengrui Pharmaceuticals Co. incorporated?
SEC records list its state or country of incorporation as F4.
Where is Jiangsu Hengrui Pharmaceuticals Co. headquartered?
SEC records list its business address as 7 KUNLUNSHAN ROAD, LIANYUNGANG, 222047.
When does Jiangsu Hengrui Pharmaceuticals Co.'s fiscal year end?
Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s fiscal year ends on December 31, per SEC records.
Which companies are similar to Jiangsu Hengrui Pharmaceuticals Co.?
Companies in our directory listed in the same country and business area as Jiangsu Hengrui Pharmaceuticals Co.: Beijing Beilu Pharmaceutical Co., Jiuzhitang Co., Acrobiosystems Co., Abbisko Cayman, Shanghai Henlius Biotech, Aurisco Pharmaceutical Co..
Investor discussion: Jiangsu Hengrui Pharmaceuticals Co.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
SEC filings and registration
- SEC name
- Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
- CIK
- 2071868
- US tickers
- JHPCY (OTC), JNGHF (OTC)
- State or country of incorporation
- F4
- Fiscal year ends
- December 31
- Business address
- 7 KUNLUNSHAN ROAD, LIANYUNGANG, 222047
- Phone
- 86-021-61053323
Listing details
- Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Ticker
- 600276
- Listing
- SSE
- Country or territory
- China
- Business scope
- Pharmaceuticals: Major
- ISIN
- CNE0000014W7
- Other listed symbols
- BMV:1276/N; GETTEX:0BO; HKEX:1276; LS:A41984; LSX:A41984; OTC:JHPCY
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio